Nabiximols

Cannabis-Based Spray Shows Early Safety Promise for Alzheimer’s Agitation—But Proof of Efficacy Still Awaited

By Benjamin Caplan, MD

Comments Off on Cannabis-Based Spray Shows Early Safety Promise for Alzheimer’s Agitation—But Proof of Efficacy Still Awaited

March 26, 2026

6 Min Read

Despite significant COVID-19 pandemic-related challenges, administering nabiximols through oral mucosa to advanced Alzheimer's dementia patients with agitation demonstrated feasibility and safety. These findings support a larger confirmatory efficacy…